YB-1 overexpression promotes a TGF-β1-induced epithelial - Mesenchymal transition via Akt activation

Biochemical and Biophysical Research Communications

Volumn 458, Issue 2, 2015, Pages 347-351

  Ha, Bin ^a   Lee, Eun Byul ^a   Cui, Jun ^a   Kim, Yosup ^a   Jang, Ho Hee ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Akt; E cadherin; Epithelial mesenchymal transition; TGF 1; YB 1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; Y BOX BINDING PROTEIN 1; YBX1 PROTEIN, HUMAN;

ADENOCARCINOMA CELL LINE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; CELL LINE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; EPITHELIUM CELL; METABOLISM; PHYSIOLOGY;

CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; Y-BOX-BINDING PROTEIN 1;

EID: 84923268973     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.114     Document Type: Article

References (30)

1. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 2003 577 584
2. J. Zavadil, and E.P. Bottinger TGF-beta and epithelial-to-mesenchymal transitions Oncogene 24 2005 5764 5774
3. H. Hugo, M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams, and E.W. Thompson Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression J. Cell. Physiol. 213 2007 374 383
4. J.P. Thiery Epithelial-mesenchymal transitions in development and pathologies Curr. Opin. Cell. Biol. 15 2003 740 746
5. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr. Opin. Cell. Biol. 17 2005 548 558
6. E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. Garcia De Herreros The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat. Cell. Biol. 2 2000 84 89
7. K.M. Hajra, D.Y. Chen, and E.R. Fearon The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Res. 62 2002 1613 1618
8. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
9. J. Shi, D.M. Wang, C.M. Wang, Y. Hu, A.H. Liu, Y.L. Zhang, B. Sun, and J.G. Song Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition Cancer Res. 69 2009 7180 7187
10. T.V. Do, L.A. Kubba, H. Du, C.D. Sturgis, and T.K. Woodruff Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition Mol. Cancer Res. 6 2008 695 705
11. M.A. Skabkin, V. Evdokimova, A.A. Thomas, and L.P. Ovchinnikov The major messenger ribonucleoprotein particle protein p50 (YB-1) promotes nucleic acid strand annealing J. Biol. Chem. 276 2001 44841 44847
12. E. Stickeler, S.D. Fraser, A. Honig, A.L. Chen, S.M. Berget, and T.A. Cooper The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 EMBO J. 20 2001 3821 3830
13. V. Evdokimova, P. Ruzanov, H. Imataka, B. Raught, Y. Svitkin, L.P. Ovchinnikov, and N. Sonenberg The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer EMBO J. 20 2001 5491 5502
14. U. Stein, K. Jurchott, W. Walther, S. Bergmann, P.M. Schlag, and H.D. Royer Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters J. Biol. Chem. 276 2001 28562 28569
15. N. Kedersha, and P. Anderson Mammalian stress granules and processing bodies Methods Enzymol. 431 2007 61 81
16. B.W. Sutherland, J. Kucab, J. Wu, C. Lee, M.C. Cheang, E. Yorida, D. Turbin, S. Dedhar, C. Nelson, M. Pollak, H. Leighton Grimes, K. Miller, S. Badve, D. Huntsman, C. Blake-Gilks, M. Chen, C.J. Pallen, and S.E. Dunn Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells Oncogene 24 2005 4281 4292
17. K. Kohno, H. Izumi, T. Uchiumi, M. Ashizuka, and M. Kuwano The pleiotropic functions of the Y-box-binding protein, YB-1 Bioessays 25 2003 691 698
18. R.C. Bargou, K. Jurchott, C. Wagener, S. Bergmann, S. Metzner, K. Bommert, M.Y. Mapara, K.J. Winzer, M. Dietel, B. Dorken, and H.D. Royer Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression Nat. Med. 3 1997 447 450
19. W. Xu, L. Zhou, R. Qin, H. Tang, and H. Shen Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome Eur. J. Haematol. 83 2009 313 319
20. T. Okamoto, H. Izumi, T. Imamura, H. Takano, T. Ise, T. Uchiumi, M. Kuwano, and K. Kohno Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression Oncogene 19 2000 6194 6202
21. P.R. Mertens, M.A. Alfonso-Jaume, K. Steinmann, and D.H. Lovett A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription J. Biol. Chem. 273 1998 32957 32965
22. A.G. Bader, K.A. Felts, N. Jiang, H.W. Chang, and P.K. Vogt Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway Proc. Natl. Acad. Sci. U. S. A. 100 2003 12384 12389
23. V. Evdokimova, C. Tognon, T. Ng, P. Ruzanov, N. Melnyk, D. Fink, A. Sorokin, L.P. Ovchinnikov, E. Davicioni, T.J. Triche, and P.H. Sorensen Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition Cancer Cell 15 2009 402 415
24. E.E. Capowski, S. Esnault, S. Bhattacharya, and J.S. Malter Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA J. Immunol. 167 2001 5970 5976
25. K. Shibahara, K. Sugio, T. Osaki, T. Uchiumi, Y. Maehara, K. Kohno, K. Yasumoto, K. Sugimachi, and M. Kuwano Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer Clin. Cancer Res. 7 2001 3151 3155
26. M. Janz, N. Harbeck, P. Dettmar, U. Berger, A. Schmidt, K. Jurchott, M. Schmitt, and H.D. Royer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 Int. J. Cancer 97 2002 278 282
27. S. Bergmann, B. Royer-Pokora, E. Fietze, K. Jurchott, B. Hildebrandt, D. Trost, F. Leenders, J.C. Claude, F. Theuring, R. Bargou, M. Dietel, and H.D. Royer YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification Cancer Res. 65 2005 4078 4087
28. A. Gal, T. Sjoblom, L. Fedorova, S. Imreh, H. Beug, and A. Moustakas Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis Oncogene 27 2008 1218 1230
29. N. Manickam, M. Patel, K.K. Griendling, Y. Gorin, and J.L. Barnes RhoA/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species Am. J. Physiol. Renal Physiol. 307 2014 F159 F171
30. B.T. Vo, D. Morton Jr., S. Komaragiri, A.C. Millena, C. Leath, and S.A. Khan TGF-beta effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway Endocrinology 154 2013 1768 1779